REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Saleticlab S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Saleticlab S.A. Profile Updated: February 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Saleticlab S.A. is an enterprise in Ecuador, with the main office in Manta. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on November 23, 2017. Saleticlab S.A. currently employs 3 (2024) people. In 2024, the company reported a net sales revenue increase of 15.53%. Over the same period, its total assets grew by 18.31%. In 2024, Saleticlab S.A.’s net profit margin increased by 0.68%.

Headquarters
Calle 16
Manta; Manabi;

Contact Details: Purchase the Saleticlab S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Saleticlab S.A. report to view the information.
Registered Capital:
Purchase the Saleticlab S.A. report to view the information.
Financial Auditors:
Purchase the Saleticlab S.A. report to view the information.
Incorporation Date:
November 23, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Saleticlab S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
15.53%▲
Total operating revenue
15.62%▲
Operating Profit/Loss (EBIT)
17.5%▲
EBITDA
17.29%▲
Net Profit/Loss for the Period
26.97%▲
Total Assets
18.31%▲
Total Equity
62.05%▲
Operating Profit Margin (ROS)
0.23%▲
Net Profit Margin
0.68%▲
Return on Equity (ROE)
-10.58%▼
Debt/Equity
-0.42%▼
Quick Ratio
-0.16%▼
Cash Ratio
0.27%▲

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Jaspharm CIA Ltda
 
Cedimed CIA Ltda
Farmacid S.A.
 
Farmabion del Ecuador C.A.
Servicios Farmaceuticos Mayorga S.A. Mayorfarma
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo